|
|
|
|
The efficacy,safety,and tolerability of subcutaneous sumatriptan in the acute treatment of cluster headache were investigated in a multicenter study over a period of up to 1 year.A total of 2,031 attacks were evaluated in 52 patients.Therapy was successful in 88%of all attacks. Freedom from pain within 15 minutes in more than 90%of all attacks treated was reported by 42%of the patients,and no decline in efficacy occurred during the course of the study.Adverse events were reported by 62%of the patients. |
|